Correlation Between Elevation Oncology and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Protalix Biotherapeutics, you can compare the effects of market volatilities on Elevation Oncology and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Protalix Biotherapeutics.
Diversification Opportunities for Elevation Oncology and Protalix Biotherapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Elevation and Protalix is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Elevation Oncology and Protalix Biotherapeutics
Given the investment horizon of 90 days Elevation Oncology is expected to under-perform the Protalix Biotherapeutics. In addition to that, Elevation Oncology is 1.75 times more volatile than Protalix Biotherapeutics. It trades about -0.06 of its total potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.25 per unit of volatility. If you would invest 227.00 in Protalix Biotherapeutics on November 9, 2024 and sell it today you would earn a total of 42.00 from holding Protalix Biotherapeutics or generate 18.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Elevation Oncology vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Elevation Oncology |
| Protalix Biotherapeutics |
Elevation Oncology and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Elevation Oncology and Protalix Biotherapeutics
The main advantage of trading using opposite Elevation Oncology and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |